Elizabeth Hunter
Philadelphia, Pennsylvania, United States
1K followers
500+ connections
About
Elizabeth Hunter is the co-founder and Chief Operating Officer of Treeswift, a company…
Activity
-
So wonderful spending some time with Ashton Kutcher! We connected at a small event this past weekend down in Palo Alto. He covered a bunch of…
So wonderful spending some time with Ashton Kutcher! We connected at a small event this past weekend down in Palo Alto. He covered a bunch of…
Liked by Elizabeth Hunter
-
It's 6:58pm. My heart is RACING. I'm worried it will come out of my chest. I am locked in my home office clicking refresh on a Chrome tab. Boom…
It's 6:58pm. My heart is RACING. I'm worried it will come out of my chest. I am locked in my home office clicking refresh on a Chrome tab. Boom…
Liked by Elizabeth Hunter
-
I just built my first web app with #Claude from Anthropic and #Cursor! The TLDR: it was a spectacular learning experience building my first app from…
I just built my first web app with #Claude from Anthropic and #Cursor! The TLDR: it was a spectacular learning experience building my first app from…
Liked by Elizabeth Hunter
Experience
-
-
-
-
-
-
-
Education
Publications
-
Catalytic antimicrobial robots for biofilm eradication
Science Robotics
See publicationG. Hwang*, A. J. Paula*, E. E. Hunter, Y. Liu, A. Babeer, B. Karabucak, K. Stebe, V. Kumar, E. Steager, and H. Koo, “Catalytic antimicrobial robots for biofilm eradication,” Sci. Robot., vol. 4, no. 29, p. eaaw2388, Apr. 2019. *Equal contribution.
-
Nanoliter Fluid Handling for Microbiology via Levitated Magnetic Microrobots
IEEE Robotics and Automation Letters
See publicationE. E. Hunter, E. B. Steager, A. Hsu, A. Wong-Foy, R. Pelrine, and V. Kumar, Nanoliter Fluid Handling for Microbiology via Levitated Magnetic Microrobots, IEEE Robotics and Automation Letters, vol. 4, no. 2, pp. 9971004, Apr. 2019.
-
3D Micromolding of Small-Scale Biological Robots
IEEE International Conference on Manipulation, Automation and Robotics at Small Scales (MARSS)
See publicationE. E. Hunter, E. W. Brink, E. B. Steager, and V. Kumar, 3D Micromolding of Small-Scale Biological Robots, in 2018 IEEE International Conference on Manipulation, Automation and Robotics at Small Scales (MARSS), Nagoya, Japan, 2018, pp. 1-6. (Best Student Paper Finalist)
-
Cell Tracking with Deep Learning and the Viterbi Algorithm
International Conference on Manipulation, Automation and Robotics at Small Scales (MARSS)
See publicationD. E. Hernandez, S. W. Chen, E. E. Hunter, E. B. Steager, and V. Kumar, Cell Tracking with Deep Learning and the Viterbi Algorithm, in 2018 International Conference on Manipulation, Automation and Robotics at Small Scales (MARSS), Nagoya, Japan, 2018, pp. 1-6.
-
Controlled Delivery of Signaling Molecules using Magnetic Microrobots
International Conference on Manipulation, Automation and Robotics at Small Scales (MARSS)
See publicationS. Das, E. E. Hunter, N. A. Delateur, E. B. Steager, R. Weiss, and V. Kumar, Controlled Delivery of Signaling Molecules using Magnetic Microrobots, in 2018 International Conference on Manipulation, Automation and Robotics at Small Scales (MARSS), Nagoya, Japan, 2018, pp. 1-5.
-
Toward Soft Micro Bio Robots for Cellular and Chemical Delivery
IEEE Robotics and Automation Letters
See publicationE. E. Hunter, E. W. Brink, E. B. Steager, V. Kumar, Toward Soft Micro Bio Robots for Cellular and Chemical Delivery, IEEE Robotics and Automation Letters, vol. 3, no. 3, pp. 1592-1599, Jul. 2018.
-
In vitro characterization of a stem-cell-seeded triple-interpenetrating-network hydrogel for functional regeneration of the nucleus pulposus
Tissue Engineering Part A
See publicationL. J. Smith, D. J. Gorth, B. L. Showalter, J. A. Chiaro, E. E. Beattie, D. M. Elliott, R. L. Mauck, W. Chen, and N. R. Malhotra, In vitro characterization of a stem-cell-seeded triple-interpenetrating-network hydrogel for functional regeneration of the nucleus pulposus., Tissue Eng. Part A, vol. 20, no. 1314, pp. 18419, Jul. 2014.
-
Effect of surface interactions and geometry on the motion of micro bio robots
Applied Physics Letters
See publicationD. Wong, E. E. Beattie, E. B. Steager, and V. Kumar, Effect of surface interactions and geometry on the motion of micro bio robots, Appl. Phys. Lett., vol. 103, no. 15, p. 153707, 2013.
-
Needle puncture injury causes acute and long-term mechanical deficiency in a mouse model of intervertebral disc degeneration
Journal of Orthopaedic Research
See publicationJ. T. Martin, D. J. Gorth, E. E. Beattie, B. D. Harfe, L. J. Smith, and D. M. Elliott, Needle puncture injury causes acute and long-term mechanical deficiency in a mouse model of intervertebral disc degeneration., J. Orthop. Res., vol. 31, no. 8, pp. 127682, Aug. 2013.
-
Comparison of Animal Discs Used in Disc Research to Human Lumbar Disc: Torsion Mechanics and Collagen Content
Spine
See publicationB. L. Showalter, J. C. Beckstein, J. T. Martin, E. E. Beattie, A. a E. Oras, T. P. Schaer, E. J. Vresilovic, and D. M. Elliott, Comparison of Animal Discs Used in Disc Research to Human Lumbar Disc: Torsion Mechanics and Collagen Content., Spine (Phila. Pa. 1976)., vol. 37, no. 15, pp. E900-E907, Jul. 2012.
Patents
-
Automated and Precise Device for Dental Plaque Detection, Monitoring and Removal
US 62/927,414
Hyun Koo, Edward Steager, Elizabeth Hunter, and Alaa Babeer
-
Small-Scale Robots for Biofilm Eradication
US 62/772,306
Hyun Koo, Kathleen Stebe, Vijay Kumar, Elizabeth Hunter, and Evan Brink
Honors & Awards
-
Forbes 30 Under 30 - Science
-
-
National Science Foundation Graduate Research Fellowship
-
More activity by Elizabeth
-
Working hard is a choice, not a requirement. Jensen Huang clearly thrives working dawn to dusk seven days a week - he's doing what he loves. But it's…
Working hard is a choice, not a requirement. Jensen Huang clearly thrives working dawn to dusk seven days a week - he's doing what he loves. But it's…
Liked by Elizabeth Hunter
-
Thanks Carla Macklin for sharing your journey as an #entrepreneur and #angelinvestor with our Weatherhead School of Management at Case Western…
Thanks Carla Macklin for sharing your journey as an #entrepreneur and #angelinvestor with our Weatherhead School of Management at Case Western…
Liked by Elizabeth Hunter
-
I was thrilled to present Kodama Autopilot at the American Loggers Council annual meeting last week and announce our collaboration with Weiler…
I was thrilled to present Kodama Autopilot at the American Loggers Council annual meeting last week and announce our collaboration with Weiler…
Liked by Elizabeth Hunter
-
Data collection for forestry, timber, and agriculture currently relies on manual techniques which are labor-intensive and time-consuming. TreeScope…
Data collection for forestry, timber, and agriculture currently relies on manual techniques which are labor-intensive and time-consuming. TreeScope…
Liked by Elizabeth Hunter
-
Today, I was deeply honored to welcome guests from Penn Engineering University of Pennsylvania and beyond as we dedicated Amy Gutmann Hall, the…
Today, I was deeply honored to welcome guests from Penn Engineering University of Pennsylvania and beyond as we dedicated Amy Gutmann Hall, the…
Liked by Elizabeth Hunter
-
I used to say "all money is green" when founders asked me about raising money. My point was that while investors matter, the primary value they will…
I used to say "all money is green" when founders asked me about raising money. My point was that while investors matter, the primary value they will…
Liked by Elizabeth Hunter
-
i think we lost our way a bit when we started talking about 'building unicorns' and not 'building companies'
i think we lost our way a bit when we started talking about 'building unicorns' and not 'building companies'
Liked by Elizabeth Hunter
-
Yesterday, on the 19th day of the month, in my 19th year as a faculty member, the 19th PhD student from my group defended his thesis (we did not pick…
Yesterday, on the 19th day of the month, in my 19th year as a faculty member, the 19th PhD student from my group defended his thesis (we did not pick…
Liked by Elizabeth Hunter
Other similar profiles
Explore more posts
-
Ryan Kosai
Excited to announce that Potato has new funding led by Draper Associates, to build a fully-autonomous AI scientist. "With $4.5 million in fresh funding, Seattle-area startup Potato is sprouting big plans to disrupt scientific research with a fully automated experimental process." https://lnkd.in/gMtY8agr I'm excited to be working with great co-workers David Welte, Ansel Santosa, and Ambrose Sterr again.
33 Comments -
Phil Morle
I had a conversation with Karl Schmieder, MS MFA on how #radicalcollaboration is needed to bring a bio-manufacturing industry to life. We talked about: Why invention alone isn’t enough: Discovery is no longer the bottleneck—industrial scaling, regulation, and consumer adoption are. The new role of orchestrators: The most valuable companies will be those that coordinate across supply chains, regulators, and corporates, turning fragmented players into functioning ecosystems. What this means for founders and investors: The future winners in biotech may not be those with the most novel science, but those who master the art of integration. https://lnkd.in/g4bshddA Kylie Porter Michele Stansfield David Weiner David Kestenbaum Mark Warner Sam Perkins Ian O'Hara Arturo Elizondo James Petrie Jim Fader Paul Riley Ed Husic MP Robyn Denholm Guy Reypert Chris Liu Rob Brown Emerald Scofield Dirk van der Kley
5 Comments -
Allan Gobbs
𝐗𝐑 𝐈𝐬 𝐍𝐨 𝐋𝐨𝐧𝐠𝐞𝐫 “𝐓𝐡𝐞 𝐅𝐮𝐭𝐮𝐫𝐞”—𝐈𝐭’𝐬 𝐓𝐨𝐝𝐚𝐲’𝐬 𝐑𝐞𝐚𝐥𝐢𝐭𝐲 At AWE USA 2025, Ori Inbar, Co‑Founder & CEO of AWE XR, confidently proclaimed: “The wait is over—XR is going mainstream.” His keynote delivered compelling insights into why 2024 served as the true breakthrough year—and why 2025 is the year XR cements itself into both business and consumer worlds. 𝐇𝐚𝐫𝐝𝐰𝐚𝐫𝐞 𝐌𝐚𝐭𝐮𝐫𝐢𝐭𝐲 + 𝐀𝐈-𝐃𝐫𝐢𝐯𝐞𝐧 𝐂𝐫𝐞𝐚𝐭𝐢𝐨𝐧 The competition between Apple, Meta, Sony Electronics, Samsung Electronics, HTC, Snap Inc., and others has brought XR devices to a new level of readiness: lighter, smarter, and more affordable. At the same time, Generative AI is dramatically reducing the complexity of content creation, allowing more people—not just specialists—to build meaningful XR experiences. 𝐄𝐧𝐭𝐞𝐫𝐩𝐫𝐢𝐬𝐞 𝐀𝐝𝐨𝐩𝐭𝐢𝐨𝐧 𝐈𝐬 𝐒𝐤𝐲𝐫𝐨𝐜𝐤𝐞𝐭𝐢𝐧𝐠 Currently, about 70% of XR revenue comes from enterprise applications across energy, utilities, manufacturing, construction, healthcare, defense, and beyond. Use cases like immersive training, digital twins, remote assistance, and surgical simulations are demonstrating clear and measurable value. 𝐗𝐑 + 𝐀𝐈 = 𝐓𝐡𝐞 𝐓𝐞𝐜𝐡 𝐏𝐨𝐰𝐞𝐫 𝐂𝐨𝐮𝐩𝐥𝐞 Ori put it best: “AI makes XR better. XR makes AI better.” XR provides the spatial and contextual data AI needs to learn, while AI accelerates the design, deployment, and personalization of XR experiences. Together, they unlock a new era of human-computer interaction. 𝐓𝐡𝐞 𝐍𝐞𝐱𝐭 𝐂𝐡𝐚𝐥𝐥𝐞𝐧𝐠𝐞: 𝐁𝐮𝐢𝐥𝐝𝐞𝐫𝐬 𝐖𝐚𝐧𝐭𝐞𝐝 With capable hardware and powerful AI tools now in place, the moment belongs to the builders—those ready to create impactful XR content and applications across industries, education, and everyday life. Developers and creatives: The infrastructure is ready. Build. Investors and innovators: Real traction. Real use cases. Real ROI. XR is no longer hype. It’s a present-day platform with real-world impact. As Ori said—XR is going mainstream. The question is: who’s building the future? #XR #SpatialComputing #AugmentedReality #MixedReality #AWE2025 #AI
2 Comments -
Milad Alucozai
Claude made 90% of AI biotech startups obsolete. Here's exactly what the surviving 10% need to do and what investors and founders need to know. First, the uncomfortable truth: Most AI biotechs were just arbitraging pharma's fear of the cloud. Building ChatGPT wrappers. Charging $100K/year for Benchling connectors that Claude now ships free. Hundreds of startups selling "AI-powered drug discovery" just became middlemen nobody needs. Many investors backed the hype. Now they're holding equity in companies solving yesterday's problems. Pharma doesn't need another chatbot. They need AI they can actually use. The winners won't have the best models. They'll make those models trustworthy, deployable, and compliant. The next $10B life sciences companies aren't competing with Anthropic. They're completing the stack Anthropic started. Here's what the surviving 10% must do: 1. Build what Claude can't Stop competing on language models. Build wet lab automation, molecular simulation engines, clinical trial infrastructure. The hard stuff. 2. Become the translation layer Pharma has Claude. They don't know how to use it. Be the partner that turns AI capability into validated drug development workflows. 3. Own specialized domains Go so deep on protein folding, ADMET prediction, or target identification that even Claude needs your expertise. 4. Create the governance framework Every pharma needs AI compliance, validation, and audit trails. Build the infrastructure that makes Claude FDA-compliant. 5. Focus on outcomes, not tools Stop selling "AI." Start selling faster drug discovery, cheaper trials, better patient outcomes. When platforms shift, fortunes are made. Not by fighting the platform, but by building on it. Salesforce created a $10B ecosystem. iOS created a $100B ecosystem. Claude for Life Sciences just laid the foundation for the first trillion-dollar biotech ecosystem. Welcome to biotech's golden age. Best time to be investing and building. #AI #Biotech #LifeSciences #VentureCapital #StartupStrategy #HealthTech
80 Comments
Explore top content on LinkedIn
Find curated posts and insights for relevant topics all in one place.
View top content